Crescent Capital holder plans $5.1M share sale
A 10% stockholder of Crescent Capital BDC, Inc. has filed to sell 525,000 CCAP shares under Rule 144, valued at about $5.1 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Crescent Capital BDC, Inc. (CCAP) has a notice of proposed sale under Rule 144 filed on behalf of Fidelity & Guaranty Life Insurance, identified as a 10% stockholder. The filing covers a proposed sale of 525,000 shares of common stock through Keefe, Bruyette & Woods on NASDAQ on or after August 24, 2026, with an aggregate market value of $5,118,750.
The notice states that Crescent Capital BDC, Inc. has 36,845,952 shares outstanding, and that the selling stockholder originally acquired 4,205,307 shares of common stock in the issuer’s November 16, 2021 initial public offering for cash.
Key Figures
Key Terms
Rule 144 regulatory
10% Stockholder financial
initial public offering (IPO) financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Crescent Capital BDC, Inc. (CCAP)?
Who is the selling security holder in the Crescent Capital BDC (CCAP) Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.